View Older Stories View More Recent Stories

Sep 18, 2017 07:00AM Rodin Therapeutics Advances Synaptic Resilience Strategy with $27 Million in Financing and Expands Board of Directors
Sep 8, 2017 05:00AM Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
Aug 30, 2017 04:06PM Form 3 SYNLOGIC, INC. For: Aug 28 Filed by: Atlas Venture Fund IX, L.P.
Aug 28, 2017 09:15AM Synlogic Completes Merger with Mirna Therapeutics
Aug 15, 2017 08:45AM The Trout Group and The Conference Forum Announce Immuno-Oncology 360° Partnership to Fight a Wider Range of Cancers
Aug 3, 2017 04:01PM Bristol-Myers Squibb (BMY) to Acquire IFM Therapeutics
Aug 3, 2017 04:00PM Bristol-Myers Squibb to Acquire IFM Therapeutics to Strengthen Oncology Pipeline Focus on Innate Immunity
Jul 18, 2017 01:53PM Form 13F-HR Atlas Venture Associates For: Jun 30
Jul 11, 2017 05:37PM Form 4 Intellia Therapeutics, For: Jul 07 Filed by: Atlas Venture Fund IX, L.P.
Jun 30, 2017 04:04PM Form D Atlas Venture Fund XI,
Jun 29, 2017 06:30AM Atlas Venture Announces $350 Million Fund XI
Jun 20, 2017 08:32AM Xtera(R) Chairman and Chief Strategy Officer to Serve as Programme Chair for SubOptic 2019
Jun 19, 2017 06:00AM Surface Oncology Expands Scientific Advisory Board with the Addition of Leading Clinical and Translational Cancer Immunotherapy Experts
Jun 1, 2017 09:00AM Ligand Enters into Worldwide OmniAb® Platform License Agreement with Surface Oncology
Jun 1, 2017 07:00AM Atlas Venture Names Kevin Bitterman as New Partner
Jun 1, 2017 07:00AM Bicycle Therapeutics Closes £40 Million ($52 Million) in Series B Financing to Advance Clinical Pipeline
Jun 1, 2017 02:00AM Bicycle Therapeutics Closes £40 Million ($52 Million) in Series B Financing to Advance Clinical Pipeline
May 23, 2017 08:30AM Scholar Rock Announces Drug Development Leaders, Michael Gilman and Shelia Violette, to Join Scientific Advisory Board
May 23, 2017 08:00AM IFM Therapeutics Appoints H. Martin Seidel as Executive Vice President of Research and Development
May 16, 2017 06:34AM Mirna Therapeutics (MIRN) to Merger with Synlogic
May 16, 2017 06:30AM Synlogic and Mirna Therapeutics Agree to Merger
May 11, 2017 11:44AM Form 13F-HR Atlas Venture Associates For: Mar 31
May 11, 2017 07:00AM Industry Veteran Peter Barrett To Lead Harvard Business School's Blavatnik Fellowship in Life Science Entrepreneurship
May 10, 2017 07:00AM Magenta Therapeutics Announces New Clinical Data on its Lead Expansion Clinical Program, MGTA-456, Presented at American Society of Gene and Cell Therapy Annual Meeting
May 2, 2017 07:00AM Magenta Therapeutics Advances Stem Cell Transplantation Strategy with $50 Million Series B Financing, Licensing of Clinical-Stage Stem Cell Expansion Program and Strategic Partnership with Be The Matc
May 2, 2017 07:00AM Be The Match BioTherapies Announces Collaboration Agreement with Magenta Therapeutics
Apr 11, 2017 09:00AM JDA Expands Leadership Team
Mar 27, 2017 09:00AM SaltDNA and Equiis Technologies Switzerland AG Announce Strategic Technology Partnership
Mar 23, 2017 09:00AM Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting
Mar 14, 2017 09:00AM Square 1 Bank Announces Credit Facility to Unum Therapeutics
Mar 13, 2017 10:39AM Form 4 Intellia Therapeutics, For: Mar 09 Filed by: Atlas Venture Associates IX, L.P.
Mar 8, 2017 08:30AM Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing
Mar 7, 2017 08:35AM Form 4 Intellia Therapeutics, For: Mar 03 Filed by: Atlas Venture Fund IX, L.P.
Feb 23, 2017 03:04PM Form SC 13D MIRAGEN THERAPEUTICS, Filed by: Atlas Venture Fund VII L P
Feb 23, 2017 06:00AM IFM Therapeutics Appoints Renowned Physicians from Academia and Industry to Clinical Advisory Board
Feb 16, 2017 09:00AM SaltDNA Combines Privacy, Control and Compliance for MiFID II in Latest Enterprise Release
Feb 13, 2017 05:26PM Form 3 MIRAGEN THERAPEUTICS, For: Feb 13 Filed by: Atlas Venture Fund VII L P
Feb 13, 2017 04:19PM miRagen Therapeutics (MGEN) Completes Merger with Signal Genetics (SGNL)
Feb 13, 2017 04:15PM miRagen Therapeutics Completes Merger with Signal Genetics and Concurrent $40.7 Million Equity Financing
Feb 10, 2017 01:12PM Form 13F-HR Atlas Venture Associates For: Dec 31
Feb 9, 2017 04:39PM Form SC 13G/A Egalet Corp Filed by: Atlas Venture Fund VII L P
Feb 9, 2017 04:39PM Form SC 13G/A ZAFGEN, INC. Filed by: Atlas Venture Fund VII L P
Feb 9, 2017 04:38PM Form SC 13G Intellia Therapeutics, Filed by: Atlas Venture Fund IX, L.P.
Feb 7, 2017 07:00AM Surface Oncology Appoints Jeff Goater as Chief Business Officer
Jan 26, 2017 07:01AM Celgene (CELG) Announces Agreement to Acquire Delinia
Jan 26, 2017 07:00AM Celgene to Acquire Delinia, Inc.
Jan 9, 2017 08:33AM Allergan (AGN) Says It Purchased an Exclusive Option Right to Acquire LTI
Jan 9, 2017 08:30AM Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential First-In-Class Breakthrough Compounds
Jan 4, 2017 08:00AM Surface Oncology Welcomes Industry Leader Daniel S. Lynch as Chairman of Board of Directors
Dec 19, 2016 09:00AM Harbour BioMed Acquires Harbour Antibodies to Create Global, Oncology-focused Biotechnology Company
View More Recent Stories View Older Stories